-
2
-
-
77957949436
-
Rapid-learning system for cancer care
-
A. P. Abernethy, L. M. Etheredge, P. A. Ganz, P. Wallace, R. R. German, C. Neti, P. B. Bach, S. B. Murphy, Rapid-learning system for cancer care. J. Clin. Oncol. 28, 4268-4274 (2010).
-
(2010)
J. Clin. Oncol.
, vol.28
, pp. 4268-4274
-
-
Abernethy, A.P.1
Etheredge, L.M.2
Ganz, P.A.3
Wallace, P.4
German, R.R.5
Neti, C.6
Bach, P.B.7
Murphy, S.B.8
-
3
-
-
66149175458
-
The Kaiser Permanente Electronic Health Record: Transforming and streamlining modalities of care
-
C. Chen, T. Garrido, D. Chock, G. Okawa, L. Liang, The Kaiser Permanente Electronic Health Record: Transforming and streamlining modalities of care. Health Aff. (Millwood) 28, 323-333 (2009).
-
(2009)
Health Aff. (Millwood)
, vol.28
, pp. 323-333
-
-
Chen, C.1
Garrido, T.2
Chock, D.3
Okawa, G.4
Liang, L.5
-
6
-
-
64349086599
-
Stimulating the adoption of health information technology
-
D. Blumenthal, Stimulating the adoption of health information technology. N. Engl. J. Med. 360, 1477-1479 (2009).
-
(2009)
N. Engl. J. Med.
, vol.360
, pp. 1477-1479
-
-
Blumenthal, D.1
-
7
-
-
77952977592
-
Liberating health data for clinical research applications
-
J. J. Nadler, G. J. Downing, Liberating health data for clinical research applications. Sci. Transl. Med. 2, 18cm6 (2010).
-
(2010)
Sci. Transl. Med.
, vol.2
-
-
Nadler, J.J.1
Downing, G.J.2
-
8
-
-
77955620286
-
Patient-Centered Outcomes Research Institute: The intersection of science and health care
-
C. Clancy, F. S. Collins, Patient-Centered Outcomes Research Institute: The intersection of science and health care. Sci. Transl. Med. 2, 37cm18 (2010).
-
(2010)
Sci. Transl. Med.
, vol.2
-
-
Clancy, C.1
Collins, F.S.2
-
9
-
-
80053121989
-
-
FDA Sentinel Initiative. http://www.fda.gov/Safety/ FDAsSentinelInitiative/ucm149343.htm.
-
-
-
-
10
-
-
40949118955
-
Centralized biorepositories for genetic and genomic research
-
G. S. Ginsburg, T. W. Burke, P. Febbo, Centralized biorepositories for genetic and genomic research. JAMA 299, 1359-1361 (2008).
-
(2008)
JAMA
, vol.299
, pp. 1359-1361
-
-
Ginsburg, G.S.1
Burke, T.W.2
Febbo, P.3
-
11
-
-
80053101919
-
-
National Academies Press, Washington, DC
-
Institute of Medicine Report, Establishing precompetitive collaborations to stimulate genomics-driven product development (National Academies Press, Washington, DC, 2011). http://www.iom.edu/Reports/2010/ Establishing- Precompetitive-Collaborations-to-Stimulate- Genomics-Driven-Product-Development. aspx.
-
(2011)
Establishing Precompetitive Collaborations to Stimulate Genomics-driven Product Development
-
-
-
12
-
-
33744808550
-
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients
-
L. A. Habel, S. Shak, M. K. Jacobs, A. Capra, C. Alexander, M. Pho, J. Baker, M. Walker, D. Watson, J. Hackett, N. T. Blick, D. Greenberg, L. Fehrenbacher, B. Langholz, C. P. Quesenberry, A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res. 8, R25 (2006).
-
(2006)
Breast Cancer Res.
, vol.8
-
-
Habel, L.A.1
Shak, S.2
Jacobs, M.K.3
Capra, A.4
Alexander, C.5
Pho, M.6
Baker, J.7
Walker, M.8
Watson, D.9
Hackett, J.10
Blick, N.T.11
Greenberg, D.12
Fehrenbacher, L.13
Langholz, B.14
Quesenberry, C.P.15
-
13
-
-
80053113758
-
-
About Our Organization
-
HMO Research Network, About Our Organization. http:// www.hmoresearchnetwork.org/about.htm.
-
-
-
-
14
-
-
64049096916
-
The microeconomics of personalized medicine: Today's challenge and tomorrow's promise
-
J. C. Davis, L. Furstenthal, A. A. Desai, T. Norris, S. Sutaria, E. Fleming, P. Ma, The microeconomics of personalized medicine: Today's challenge and tomorrow's promise. Nat. Rev. Drug Discov. 8, 279-286 (2009).
-
(2009)
Nat. Rev. Drug Discov.
, vol.8
, pp. 279-286
-
-
Davis, J.C.1
Furstenthal, L.2
Desai, A.A.3
Norris, T.4
Sutaria, S.5
Fleming, E.6
Ma, P.7
-
15
-
-
80053108882
-
-
Centers for Medicare and Medicaid Services Research and Demonstration Grant Options Overview
-
Centers for Medicare and Medicaid Services Research and Demonstration Grant Options Overview. http:// www.cms.hhs.gov/ResearchDemoGrantsOpt.
-
-
-
-
16
-
-
78149301242
-
A policy approach to the development of molecular diagnostic tests
-
K. A. Schulman, S. R. Tunis, A policy approach to the development of molecular diagnostic tests. Nat. Biotechnol. 28, 1157-1159 (2010).
-
(2010)
Nat. Biotechnol.
, vol.28
, pp. 1157-1159
-
-
Schulman, K.A.1
Tunis, S.R.2
-
17
-
-
79959309141
-
Deep sequencing of patient genomes for disease diagnosis: When will it become routine?
-
S. F. Kingsmore, C. J. Saunders, Deep sequencing of patient genomes for disease diagnosis: When will it become routine? Sci. Transl. Med. 3, 87ps23 (2011).
-
(2011)
Sci. Transl. Med.
, vol.3
-
-
Kingsmore, S.F.1
Saunders, C.J.2
-
18
-
-
34548694743
-
Integrating molecular medicine into the US health-care system: Opportunities, barriers, and policy challenges
-
P. A. Deverka, T. Doksum, R. J. Carlson, Integrating molecular medicine into the US health-care system: Opportunities, barriers, and policy challenges. Clin. Pharmacol. Ther. 82, 427-434 (2007).
-
(2007)
Clin. Pharmacol. Ther.
, vol.82
, pp. 427-434
-
-
Deverka, P.A.1
Doksum, T.2
Carlson, R.J.3
-
19
-
-
3543052218
-
From pharmacogenetics to personalized medicine: A vital need for educating health professionals and the community
-
F. W. Frueh, D. Gurwitz, From pharmacogenetics to personalized medicine: A vital need for educating health professionals and the community. Pharmacogenomics 5, 571-579 (2004).
-
(2004)
Pharmacogenomics
, vol.5
, pp. 571-579
-
-
Frueh, F.W.1
Gurwitz, D.2
-
20
-
-
80051552562
-
Genomic risk profi ling: Attitudes and use in personal and clinical care of primary care physicians who off er risk profi ling
-
S. B. Haga, M. M. Carrig, J. M. O'Daniel, L. A. Orlando, L. A. Killeya-Jones, G. S. Ginsburg, A. Cho, Genomic risk profi ling: Attitudes and use in personal and clinical care of primary care physicians who off er risk profi ling. J. Gen. Intern. Med. 26, 834-840 (2011).
-
(2011)
J. Gen. Intern. Med.
, vol.26
, pp. 834-840
-
-
Haga, S.B.1
Carrig, M.M.2
O'Daniel, J.M.3
Orlando, L.A.4
Killeya-Jones, L.A.5
Ginsburg, G.S.6
Cho, A.7
-
21
-
-
80053105538
-
-
note
-
Funding: G.S.G.'s work is supported by grants from the Duke Endowment, the Duke University Health System, the Department of the Army (W81XWH-05-1-0383), National Cancer Institute (2RC2 CA-148041-02), and Pfi zer. A.P.A. has research funding from NIH, U.S. Agency for Healthcare Research and Quality, Robert Wood Johnson Foundation, Pfi zer, Eli Lilly, Bristol Meyers Squibb, Helsinn Therapeutics, Amgen, Kanglaite, Alexion, Biovex, DARA Therapeutics, Novartis, and Mi-Co; these funds are all distributed to Duke University Medical Center to support research. Competing interests: G.S.G. consults for Pappas Ventures, CardioDx, Novartis, and Universal Oncology.
-
-
-
|